Announcements Trials
Browse Landscape

Status

Active not recruiting 2

Sponsor Class

OTHER 2

Study Type

Observational 2

Sponsor

Cancer Type

Genitourinary 1Breast 1

Conditions

Drug-Related Side Effects and Adverse Reactions 2Cardiovascular Diseases 2Cardiotoxicity 2Prostatic Neoplasms 1Neoplasm Metastasis 1Breast Neoplasms 1

Interventions

Echocardiography 11Electrocardiography 5Trastuzumab 4Social Determinants of Health 2Doxorubicin 2Chemoradiotherapy 2Blood Specimen Collection 2Antineoplastic Agents 2Vascular Stiffness 1Standard of Care 1Resistance Training 1Pulse Wave Analysis 1Positron Emission Tomography Computed Tomography 1Magnetic Resonance Spectroscopy 1Immunomodulating Agents 1Hematologic Tests 1Gonadal Steroid Hormones 1Exercise Test 1EGFR tyrosine kinase inhibitor 324674 1Clinical Laboratory Techniques 1Cisplatin 1Cardiography, Impedance 1Anthracyclines 1Amplified Fragment Length Polymorphism Analysis 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Observational × Cardiotoxicity × Social Determinants of Health × Clear all
NCT05096338 2026-03-23

PCT

Abramson Cancer Center at Penn Medicine

Active not recruiting
200 enrolled
Genitourinary

Cardiovascular Diseases, Prostatic Neoplasms, Drug-Related Side Effects and Adverse Reactions, Cardiotoxicity

NCT05078190 2025-11-06

CCT2

Abramson Cancer Center at Penn Medicine

Active not recruiting
200 enrolled
Breast

Breast Neoplasms, Cardiovascular Diseases, Drug-Related Side Effects and Adverse Reactions, Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡